~~<i id='C21772A408'><strike id='C21772A408'><tt id='C21772A408'><pre id='C21772A408'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

knowledge

author：fashion 2025-09-29 09:29:37 - browse：5

the shape of a medical note connected by dots and lines — health tech coverage from STAT — Adobe

In recent months, the federal government has repeatedly told Medicare Advantage insurers that they cannot use artificial intelligence or algorithms to deny medical services the government routinely covers.

But in finalizing a rule to that effect, it also stepped into a thicket of questions from insurers about a technology that is especially difficult to pin down: What is AI? Can it be used at all to make decisions about the coverage of older patients? If so, how?

This week, the federal agency that oversees Medicare sought to boil it all down into a simple directive: Put the circumstances of the individual patient first, and your algorithm second.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： When prostate cancer spreads, where it goes matters

entertainment

Wikipedia

focus

knowledge

focus

INAFASSBENDER/AFPviaGettyImagesWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup tog

WSS

With measles on the rise, a personal story of a devastating disease

With measles on the rise, a personal story of a devastating disease

Addiction experts warn against a second 'war on drugs'

Bird flu: Don't repeat Covid's 'health versus the economy' framing

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

Congress may force more Covid

explore

knowledge

entertainment

Activists slam private health insurers over coverage restrictions

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

Peter Hotez and the public health issue of online harassment

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Addiction experts warn against a second 'war on drugs'

DIEP, the 'gold standard' of breast reconstruction, is under threat

When prostate cancer spreads, where it goes matters

Wikipedia

A new drug could help frostbite victims avoid its ravages

Arc Institute generative AI designs new CRISPR systems

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

focus

focus

knowledge

focus